Publications by authors named "Ruud Ruiter"

Claim this Profile
P
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myeloma.
Wassilis S C Bruins, Rosa Rentenaar, John Newcomb, Wenrou Zheng, Ruud W J Ruiter

Hemasphere· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138.
Jort J van der Schans, Ziyu Wang, Jennemiek van Arkel, Thijs van Schaik, Afroditi Katsarou, Ruud Ruiter

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.
Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik, Jorge Mansilla-Soto, Dionysia Kefala, Ruud Ruiter

Sci Transl Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma.
Arwen Stikvoort, Jort van der Schans, Subhashis Sarkar, Renée Poels, Ruud Ruiter

Hemasphere· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma.
Lisa C Holthof, Hilma J van der Horst, Susan E van Hal-van Veen, Ruud W J Ruiter, Fengzhi Li

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymeric micelles loaded with carfilzomib increase tolerability in a humanized bone marrow-like scaffold mouse model.
Aida Varela-Moreira, Demian van Straten, Heleen F van Leur, Ruud W J Ruiter, Anil K Deshantri

Int J Pharm X· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma.
Anil K Deshantri, Marcel H A M Fens, Ruud W J Ruiter, Josbert M Metselaar, Gert Storm

Hemasphere· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
Esther Drent, Renée Poels, Ruud Ruiter, Niels W C J van de Donk, Sonja Zweegman

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
Jyoti Naik, Maria Themeli, Regina de Jong-Korlaar, Ruud W J Ruiter, Pino J Poddighe

Haematologica· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma.
Anil K Deshantri, Marcel H Fens, Ruud W J Ruiter, Josbert M Metselaar, Gert Storm

J Control Release· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis